Molecular profiling of long‐term responders to immune checkpoint inhibitors in advanced non‐small cell lung cancer

Immunotherapy has transformed advanced non‐small cell lung cancer (NSCLC) treatment strategies and has led to unprecedented long‐lasting responses in some patients. However, the molecular determinants driving these long‐term responses remain elusive. To address this issue, we performed an integrativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Frigola, Joan, Navarro, Alejandro, Carbonell, Caterina, Callejo, Ana, Iranzo, Patricia, Cedrés, Susana, Martinez‐Marti, Alex, Pardo, Nuria, Saoudi‐Gonzalez, Nadia, Martinez, Debora, Jimenez, Jose, Sansano, Irene, Mancuso, Francesco M., Nuciforo, Paolo, Montuenga, Luis M., Sánchez‐Cespedes, Montse, Prat, Aleix, Vivancos, Ana, Felip, Enriqueta, Amat, Ramon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024716/
https://www.ncbi.nlm.nih.gov/pubmed/33342055
http://dx.doi.org/10.1002/1878-0261.12891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024716/
https://www.ncbi.nlm.nih.gov/pubmed/33342055
http://dx.doi.org/10.1002/1878-0261.12891

Ejemplares similares